User profiles for Mark D Hicar

Mark D. Hicar

Associate Professor, University at Buffalo
Verified email at buffalo.edu
Cited by 1741

Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors

…, PA McGraw, FS House, CJ Keefer, MD Hicar… - Nature, 2008 - nature.com
Investigation of the human antibody response to influenza virus infection has been largely
limited to serology, with relatively little analysis at the molecular level. The 1918 H1N1 …

COVID-19 associated multisystem inflammatory syndrome in children (MIS-C) guidelines; a Western New York approach

…, SJ Turkovich, OG Gomez-Duarte, MD Hicar - Progress in pediatric …, 2020 - Elsevier
COVID-19, a severe viral respiratory infection caused by SARS-CoV-2, affects all age groups,
yet it is more severe in elderly and individuals with co-morbidities. Recently, a severe multi-…

[HTML][HTML] COVID-19 in newborns and infants—low risk of severe disease: silver lining or dark cloud?

M Rawat, P Chandrasekharan, MD Hicar… - American journal of …, 2020 - thieme-connect.com
One hundred years after the 1918 influenza pandemic, we now face another pandemic with
the severe acute respiratory syndrome–novel coronavirus-2 (SARS-CoV-2). There is …

[HTML][HTML] Decreased clinical severity of pediatric acute COVID-19 and MIS-C and increase of incidental cases during the omicron wave in comparison to the delta wave

PO Kenney, AJ Chang, L Krabill, MD Hicar - Viruses, 2023 - mdpi.com
This study describes differences in clinical presentation in hospitalized children with acute
COVID-19 and MIS-C between the Delta and Omicron (BA.1.1) waves in a tertiary children’s …

[HTML][HTML] Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis

…, F Stefanovic, B Switzer, MD Hicar… - … for ImmunoTherapy of …, 2021 - ncbi.nlm.nih.gov
Background Immune checkpoint inhibitors (ICI) have emerged as a front-line therapy for a
variety of solid tumors. With the widespread use of these agents, immune-associated toxicities …

Frequency and genetic characterization of V (DD) J recombinants in the human peripheral blood antibody repertoire

BS Briney, JR Willis, MD Hicar, JW Thomas… - …, 2012 - Wiley Online Library
Antibody heavy‐chain recombination that results in the incorporation of multiple diversity ( D
) genes, although uncommon, contributes substantially to the diversity of the human …

COVID-19 associated multisystem inflammatory syndrome in children (MIS-C) guidelines; revisiting the Western New York approach as the pandemic evolves

…, OS Alibrahim, OG Gomez-Duarte, MD Hicar - Progress in Pediatric …, 2021 - Elsevier
Multisystem inflammatory syndrome of children (MIS-C) continues to be a highly concerning
diagnosis in those recently infected with SARS-CoV-2. The diagnosis of MIS-C cases will …

Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome

…, PS Dayan, M Dale, AD Boneparth, MD Hicar… - Journal of Allergy and …, 2022 - Elsevier
Hicar) at the University of Buffalo (Fig E3, B). Further review of the NK cell compartment via
UMAP analysis demonstrated marked and obvious changes in the phenotype of NK cells in …

[HTML][HTML] B cells and antibodies in Kawasaki disease

ME Lindquist, MD Hicar - International Journal of Molecular Sciences, 2019 - mdpi.com
The etiology of Kawasaki disease (KD), the leading cause of acquired heart disease in
children, is currently unknown. Epidemiology supports a relationship of KD to an infectious …

Obesity and Outcomes of Kawasaki Disease and COVID-19–Related Multisystem Inflammatory Syndrome in Children

…, GL Goldenberg, KC Harris, MD Hicar… - JAMA network …, 2023 - jamanetwork.com
Importance Obesity may affect the clinical course of Kawasaki disease (KD) in children and
multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19. Objective …